Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 11:41 AM UTC
| NCT Number | NCT06692738 |
| Recruiting Status | Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,160 participants |
| Active Locations | 77 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 13, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT06692738 is currently recruiting participants. This phase3 study for non-small cell lung cancer is actively seeking new participants at 77 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06692738 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 77 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06692738 was last updated 2 weeks ago (August 13, 2026). HelloStudys verifies this status automatically.